- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.12.25 | Kestra Medical Technologies stock price target raised by Stifel to $30 | 1 | Investing.com | ||
| 12.12.25 | Stifel hebt Kursziel für Kestra Medical Technologies auf 30 $ an | 2 | Investing.com Deutsch | ||
| 12.12.25 | Kestra Medical Technologies stock price target raised to $30 from $27 at Piper Sandler | 1 | Investing.com | ||
| 11.12.25 | Earnings Call Transkript: Kestra Medical Technologies Q2 2025 zeigt starkes Umsatzwachstum | 1 | Investing.com Deutsch | ||
| 11.12.25 | Kestra Medical Technologies, Ltd. GAAP EPS of -$0.64 misses by $0.05, revenue of $22.56M beats by $1.6M | 1 | Seeking Alpha | ||
| 11.12.25 | KESTRA MEDICAL TECHNOLOGIES, LTD. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 11.12.25 | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results | 127 | GlobeNewswire (Europe) | KIRKLAND, Wash., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 11.12.25 | KESTRA MEDICAL TECHNOLOGIES, LTD. - 8-K, Current Report | - | SEC Filings | ||
| 03.12.25 | Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results | 1 | GlobeNewswire (USA) | ||
| 03.12.25 | Kestra Medical Technologies prices $138M offering | 2 | MassDevice | ||
| 03.12.25 | Kestra Medical prices upsized $138M offering | 4 | Seeking Alpha | ||
| 03.12.25 | Kestra Medical Technologies prices upsized public offering at $23 per share | 5 | Investing.com | ||
| 03.12.25 | Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares | 2 | GlobeNewswire (USA) | ||
| 01.12.25 | Kestra Medical Technologies sees Q2 revenue between $22.2M and $22.6M | 3 | Seeking Alpha | ||
| 01.12.25 | Kestra Medical Technologies announces public offering of common shares | 2 | Seeking Alpha | ||
| 01.12.25 | Kestra Medical announces public offering of 5.5 million shares | 2 | Investing.com | ||
| 01.12.25 | Kestra Medical Technologies, Ltd. Announces Primary Public Offering of Common Shares | 1 | GlobeNewswire (USA) | ||
| 01.12.25 | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results | 206 | GlobeNewswire (Europe) | KIRKLAND, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported preliminary financial... ► Artikel lesen | |
| 01.12.25 | KESTRA MEDICAL TECHNOLOGIES, LTD. - S-1, General form for registration of securities | - | SEC Filings | ||
| 01.12.25 | KESTRA MEDICAL TECHNOLOGIES, LTD. - 8-K, Current Report | - | SEC Filings |
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,010 | -1,64 % | ECKERT & ZIEGLER SE - Stabilität als strategische Basis | ||
| HIMS & HERS HEALTH | 28,740 | +0,74 % | HIMS Stock On A Losing Spree: Here's Why | ||
| RADNET | 60,50 | -0,82 % | RadNet, Inc.: GE HealthCare and RadNet's DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning | Collaboration aims to expand existing U.S. relationship combining GE HealthCare's mammography systems with DeepHealth's Breast Suite to include a worldwide distribution arrangementIntends to integrate... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 30,760 | -2,22 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 38,400 | +2,54 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| INFUSYSTEM | 7,350 | -0,68 % | InfuSystem Holdings, Inc - 8-K, Current Report | ||
| IRADIMED | 84,00 | +1,82 % | Insider Unloading: Roger E Susi Sells $488K Worth Of iRadimed Shares | ||
| BETA BIONICS | 29,250 | -4,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,140 | -1,74 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,170 | -1,45 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 47,730 | -2,55 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| GENEDX | 132,30 | +1,72 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 25,740 | +0,23 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,225 | +2,41 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 39,620 | -0,95 % | CARL ZEISS MEDITEC AG: Ruhe vor dem nächsten Takt |
Das Unternehmen KESTRA MEDICAL TECHNOLOGIES LTD kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -8,14 % bei einem Aktienkurs von 24,360 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KESTRA MEDICAL TECHNOLOGIES LTD finden Sie auf Wallstreet Online.